ABSTRACT
INTRODUCTION
Medicinal plants are used in the whole world and have a growing economic importance (Agra et al., 2007) . The use of plant parts to treat human or animal disease is as old as the disease itself and herbal medicine was the major form of medicine in West Africa especially in Benin. Besides, 80% of developing countries population depends on traditional medicines for their primary health care and 25% of the drugs are based on plants and their derivatives (Azu & Onyeagba, 2007) . In Benin, medicinal plant knowledge and exploitation remain a permanent priority. Benin medicinal flora is rich and medicinal plant knowledge nowadays has a great development. Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis belong to this flora (Akoègninou et al., 2006) and are well known in many African countries. They appear to be the most studied species regarding their traditional uses and for their pharmacological properties (Ngueyem et al., 2009; Gong et al., 2012) . According to ethnoveterinary surveys in Benin as in other African countries, these three plants are used as anthelmintics in traditional human and veterinary medicine (Kabore et al., 2007 , Kone et al., 2008 Djoueche et al., 2011) . Validation of plants' uses in traditional medicine is not only involved in ethnobotanical studies (Adjanohoun et al., 1999) , but also by evaluation of biological and chemical properties (Hounzangbé -Adoté, 2000; Lagnika, 2005) . The fact that few plants from the Beninese pharmacopoeia were subject of clinical investigation; it was decided to study anthelmintic properties of these three plants against gastro-intestinal parasites on small ruminants. Because in the whole world, the strongyles are recognized as one of the first causes of production losses (Gbangboché et al, 2005) . The treatment of these parasites and other diseases is done using synthetic molecules. While the exclusive use of synthetic drugs in health many obstacles currently limit prophylaxis. First, some parasites have developed resistance to anthelmintics such as benzimidazoles, Levamisole, and even now to ivermectin because of too frequent use (Brunet, 2008) . Moreover, routine deworming regress youngs' immunity development (Brunet, 2008) . In additional, manufactured drugs are unavailable and more expensive to rural population and when they are effective, these drugs are harmful to environment because of their remanence. This manuscript comprises the first study entirely devoted to a review of all uses of zootherapeutic remedies in West Africa, using historical documents, already published sources and original data from field surveys. We will also highlight some possible conservation problems that those uses might cause for some species of Bridelia ferruginea, Combretum glutinosum and Mitragina inermis plants.
OBJECTIVES
This study examined native anthelmintic activity against gastro-intestinal parasitic nematode of small ruminants Djallonké (West African Dwarf Sheep) plants of Bridelia ferruginea, Combretum glutinosum and Mitragina inermis and confirms their uses in traditional veterinary medicine.
METHODOLOGY AND RESULTS

Botany description
Botany of Bridelia ferruginea (figure 1): The genus Bridelia Willd consists of about approximately 60-70 species including B. atroviridis, B. cathartica, B. ferruginea, B. micrantha, B. ovate, B. siamensis, B. tomentosa, B. tulasneama. All are native to Africa, Asia and Australia (Rashid, 2000) . B. ferruginea and B. micrantha appear to have been the most studied. B. ferruginea is a small non-laticiferous scaly tree or shrub that grows to about 4 meters high. The plant often bears spines and may be slash crimson coloured. The leaves may be small to medium sized, simple, alternate, spiral or distichous, broadly elliptic and pubescent. They are also pinnately veined with entire margin and an acuminate or acute apex (GHP, 1992) .
A review of Bridelia ferruginea, Combretum glutinosum and Mitragina inermis plants used in zootherapeutic remedies in West Africa. Botany of Mitragyna inermis (figure 3): The genus Mitragyna belongs to Rubiaceae family and is found in swampy territory in the tropical and subtropical regions of Asia and Africa. There is six species: M. speciosa (Korth.), M. tubulosa (Arn.), M. parvifolia (Roxb, Korth), M.hirsuta (Havi1), M. diversifolia (Wall. ex G. Don) and M. rotundifolia (Roxb, O.Kuntze.), widely grow in India and Asia (Puff et al., 2005) . Other four species, M. ciliate, M. inermis, M. stipulosa and M. africanus, widely grow in west African. Mitragyna inermis falls under the Rubiaceae family, and is a medium-to-tall deciduous shrub, growing to around 10 m in height with a trunk of wide diameter and light-colored bark. The leaves are light green and opposite and oval-shaped with a short blunt point, around 6 to 9 cm in length. The young leaves and twigs are red in colour. The tree blooms from May to September into small, fragrant white flowers, in round heads of up to 2 cm in diameter on short stalks. The tree bears fruits yearround that are hard, woody and spherical clusters of capsules. Mitragyna inermis is most traditional (ethnomedicinal) uses (Gong et al., 2012) . A review of Bridelia ferruginea, Combretum glutinosum and Mitragina inermis plants used in zootherapeutic remedies in West Africa.
METABOLITES OCCURRING IN THE PLANTS
Phytochemical studies carried out in Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis have showed the presence of many classes of secondary metabolites, including quinones, catechic and gallic tannins, alkaloids, sterols, polyterpenes, polyphenols, reducing compounds, flavonoids, saponins, phenols and tannins (Akuodor et al., 2011; Sore et al., 2012; ) . Several unusual compounds have also been isolated from the three plants like lignans (deoxypodophyllotoxin, 5'- punicalagin and combreglutinin (Traore, 1999) .The presence of indole and oxindole alkaloids from the leaves of Mitragyna inermis have been described by Shellard & Sarpong. (1967) . From the bark of M. inermis, two 27-nortriterpenoid glycosides, named inermiside I and II were isolated and their structures determined based on extensive 2D-NMR and MS spectral analysis as 6-deoxy- Extracts have antioxidant property and α-Glucosidase inhibitory activity (IC50 = 1.4 ± 0.04 µg / ml) for B. ferruginea higher than the reference compound acarbose (IC50 = 726 ± 15 mg / ml).
Bothon et al., 2012
Hexane and ethyl acetate extract from leaves
Antioxidant assay and Artemia salina test
The test showed an IC50 value of 158.2µg/ml, which is quite significant, compared with that of the gallic acid, 201 µg/ml. Artemia salina test showed an acute toxicity with LC50 value of 319 µg/ml and lethal dose with LC50 value of 5.86 µg/ml indicating that that B. ferruginea could be a source of cytotoxic and antioxidant agents.
Atolani et al., 2012
Anti-inflammatory activity Aqueous extract of the stem bark
Tail immersion mice test and Yeast-induced hyperpyrexia test
Extract significantly attenuated the spinalpain sensation against conduction heat in mice. The maximum nociceptic effect was observed at higher dose (100 mg/kg) which was comparable to that of morphine (10 mg/kg).The extract at the dose of 25, 50 and 100 mg/kg caused a more significant reduction in rectal temperature. Extracts of these plants were tested on three strains of Plasmodium falciparum, FcB1-Colombia and FcM29-Cameroon (chloroquine-resistant strains) and a Nigerian chloroquine-sensitive strain. But extract has effects on the symptoms of malaria (fever, headaches, and so on) rather than on the parasite itself at least in regards with our results on the parasite inhibition
Mustofa et al., 2000
Anti-diabetic effect Stem bark ethanol extract Hypoglycaemic effects of the ethanol extract of M. inermis on blood glucose levels of alloxan induced diabetic albino rats have been investigated. The results revealed that the plant possessed hypoglycaemic activity. Doses of 250, 350 and 450 mgkg-1 body weight intraperitoneally (i.p.) were administered to the rats but the 350 mg/kg-1 dose exhibited the highest hypoglycaemic potentials.
Adoum et al.,
Antibacterial activity
Methanol leaf extract Disc diffusion method Extract showed antibacterial activity on Staphlococcus aureus, Escherichia coli and Klebsiella pneumonia with minimum inhibitory concentration of 50 mg/ml, 50 mg/ml and 25 mg/ml respectively. The activity was concentration dependent having no effect on tested concentration of 35.5 mg/ml and 75 mg/ml on Staphlococcus aureus and Escherichia coli while at 18.75 mg/ml on Klebsiella pneumoniae. The extract was bactericidal at concentration of 100 mg/ml on Staphlococcus aureus and Klebsiella pneumoniae while 200 mg/ml on Escherichia coli 
DISCUSSION
In this review, Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis possessed wide-reaching pharmacological actions, including anti-diabetic, cardiovascular disease antibacterial, anti-inflammatory, antispasmodic and antiplasmodial activity. In studies evaluating of three plants antibacterial activity, agar diffusion assays method was used and the extracts used were obtained with different solvents (ethanol, chloroform, methanol, petroleum ether, water) . Activities were observed against the following bacterial species: Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella species, Streptococcus species, Proteus vulgaris, Klebsiella species, Sarcina lutea, Micrococcus luteus and Bacillus subtilis (Owoseni et al., 2010) , except extract of Bridelia ferruginea's leaf which had no antimicrobial activity against any of the clinical isolates (Adebayo et al., 2009) . In general, this study showed that leaves and stem bark of Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis was the organ mostly used and different extracts from leaves and stem bark at different concentrations significantly inhibited the growth of Staphylococcus aureus, Candida albicans, Staphylococcus epidermidis, Escherichia coli, Streptococcus lactis, Proteus vulgaris, Proteus mirabilis, Streptococcus pyogenes and Klebsiella sp. Besides activity showed against Staphylococcus aureus and Candida albicans may justify the use of the Bridelia ferruginea bark as mouthwash in Nigerian and Ivorian traditional medicine (Ozerov et al., 1994) . Mitragyna inermis and Combretum. Glutinosum were selected by ethnobotanical survey as plants commonly used by traditional healers for the treatment of malaria (Mustofa et al., 2000 ; ) . Extracts of these plants were tested in vitro on three strains of Plasmodium falciparum, FcB1-Colombia and FcM29-Cameroon (chloroquine-resistant strains) or Vietnamian Plasmodium falciparum chloroquine-resistant strain W2 and a Nigerian chloroquine-sensitive strain for an evaluation of antiplasmodial activity in vitro (Zongo et al., 2011) . These plants could be effectively more active on Plasmodium falciparum on human, as it is the case for plants containing prodrugs non active by themselves but which can be metabolised to active drugs (Mustofa et al., 2000) .The antioxidant and anti-inflammatory properties were only evaluated in this review for leaves and barks of Bridelia ferruginea by DPPH and carrageenan-induced paw edema tests in mice assays respectively. Extracts of the barks had the highest DPPH and ABTS free radical scavenging activity (Bothon et al., 2012) and for antiinflammatory activity aqueous extract of the stem bark was the most active (Akuodor et al., 2011) . These findings provide some evidence for the traditional use of Bridelia ferruginea for the rheumatic pain, diarrhoea, dysentery, intestinal disorders, female sterility, as anthelmintic for roundworm and in the treatment of cystitis in Nigeria and Congo Kinshasa (Cimanga et al., 2001) . Adoum et al. (2012) and Taiwo et al. (2012) demonstrated an antidiabetic effect of leaves and bark's extracts of Bridelia Ferruginea and Mitragyna inermis. In their studies, the dose of 250 mg/kg and 350 mg/kg of the extract was respectively the most effective, among the doses tested. It produced a significant hypoglycemic and antidiabetic activity. This study demonstrated the potential antidiabetic properties of extract of Bridelia. Ferruginea and Mitragyna inermis for both type 1 and type 2 diabetes, justifying its traditional use in the treatment of this disease. All of the above results contribute to justify the use of the plant in traditional medicine for treating various conditions, particularly infections and diabetes. This study has showed that the three plants treat several diseases because of their different properties and. Through this review, we have the certitude that leaves of plants have never been studied for their anthelmintic properties and will enable us to continue our PhD thesis.
CONCLUSION
Results of this review contribute to the validation of the popular use of Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis in the treatment of bacterial, fungal, malaria and viral infections and cardiovascular problems, among others. Anthelmintic properties of these plants were not found in this study thus we can screen anthelmintic activities of Bridelia ferruginea, Combretum glutinosum and Mitragyna inermis leaves against gastrointestinal parasites of small ruminants to confirm their use in traditional veterinary medicine plants.
